Navigation Links
Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
Date:8/19/2009

Nano-bio material kills cancer cells, leaves healthy cells in unharmed

Argonne, Ill. (Vocus) August 19, 2009 -- Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.

Thousands of people die from malignant brain tumors every year, and the tumors are resistant to conventional therapies. This nano-bio technology may eventually provide an alternative form of therapy that targets only cancer cells and does not affect normal living tissue.

"It is a real example of how nano and biological interfacing can be used for biomedical application," said scientist Elena Rozhkova with Argonne's Center for Nanoscale Materials. "We chose brain cancer because of its difficulty in treatment and its unique receptors."

This new therapy relies on a two-pronged approach. Titanium dioxide is a versatile photoreactive nanomaterial that can be bonded with biomolecules. When linked to an antibody nanoparticles recognize and bind specifically to cancer cells. Focused visible light is shined onto the affected region, and the localized titanium dioxide reacts to the light by creating free oxygen radicals that interact with the mitochondria in the cancer cells. Mitochondria act as cellular energy plants, and when free radicals interfere with their biochemical pathways, mitochondria receive a signal to start cell death.

"The significance of this work lies in our ability to effectively target nanoparticles to specific cell surface receptors expressed on brain cancer cells," said Dr. Maciej S. Lesniak, Director of Neurosurgical Oncolog
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
2. University of Iowa professor identifies new eating disorder
3. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
4. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
5. Tulane University to receive $14M for international HIV/AIDS program
6. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
7. Boston University School of Medicine researcher recipient of Memory Ride Grant
8. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
9. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
10. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
11. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 
(Date:9/23/2014)... 2014 (HealthDay News) -- The U.S. National Institutes ... funding in scientific trials to encourage researchers to ... The supplemental monies were provided to 82 ... immunology, cardiovascular physiology, neural circuitry, and behavioral health, ... "This funding strategy demonstrates our commitment to moving ...
(Date:9/23/2014)... that you may want to get screened and treated ... knife. According to a first-of-its-kind study in the ... journal of the American Society of Anesthesiologists (ASA), patients ... condition prior to surgery are less likely to develop ... , "OSA is a common disorder that affects millions ...
(Date:9/23/2014)... (Sept. 23, 2014) A patient survives life-threatening ... (ICU) to support his or her affected vital ... It,s a scenario well-known to physicians, who understand ... ill patients often results in significant morbidity, mortality, ... interdisciplinary team of George Washington University (GW) researchers ...
(Date:9/23/2014)... Royal Sport Ultra Clean 100 is the ... of premium sports nutrition products. Its gluten free formula ... without artificial colors or dyes, fillers, added sugar and ... shelves at select GNC retailers, on GNC.com, and through ... a limited time special on its products. Customers can ...
(Date:9/23/2014)... 23, 2014 Airbus Helicopters Inc. (AHI) ... honored as the 2014 Vision Zero Aviation Safety ... database, a free flight safety service the company ... Manager - Air Medical Specialist for Airbus Helicopters Inc., ... $10,000 check during the Air Medical Transport Conference Annual ...
Breaking Medicine News(10 mins):Health News:NIH Adds $10M to Encourage Gender Balance in Clinical Trials 2Health News:New research suggests sleep apnea screening before surgery 2Health News:Interdisciplinary research team finds method for more precise diagnosis of pneumonia 2Health News:Interdisciplinary research team finds method for more precise diagnosis of pneumonia 3Health News:Sports Nutrition Brand, Royal Sport LTD, Introduces 'Clean,' Gluten Free Protein Supplement, Royal Sport Ultra Clean 100™ 2Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 2Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 3Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 4
... 30 Turner Construction Company, the nation,s largest ... $323 million state-of-the-art Greenfield replacement hospital for Virtua ... for the project that is scheduled for completion ... technologies in order to ensure quality clinical services ...
... NASHVILLE, Tenn., Jan. 30 Avondale Partners, a ... that Brian,Williams has joined the firm as a ... Williams comes to Avondale ... focused on hospitals, nursing homes and behavioral health ...
... 30 Rev. Larry Snyder, president of Catholic ... reauthorization and expansion of the State Children,s Health ... children from low-income families that do not qualify ... need to reach agreement on a compromise version ...
... Physicians Healthcare Management Group, Inc. (Phyhealth) ... maintenance organizations (HMOs) in partnership with physicians and ... malpractice insurer, today released the following letter to ... year, a new Congress and a new administration ...
... Medco Health Solutions, Inc. (NYSE: MHS ) plans ... a press release before the market opens on Tuesday, Feb. ... conference call to review the financial results, outlook and related ... live conference call via telephone: , Dial in: (800) ...
... Much remains unknown about these treatments for menopausal ... News) -- They,re marketed as "bio-identical" hormones or ... do everything from helping menopausal women lose weight ... and sometimes even more effective than conventional hormone-replacement ...
Cached Medicine News:Health News:Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J. 2Health News:Avondale Partners Expands Coverage With Healthcare Analyst 2Health News:Catholic Charities USA Praises Congress for Protecting Health Care for Low-income Children 2Health News:Phyhealth Provides Update to Shareholders 2Health News:Phyhealth Provides Update to Shareholders 3Health News:Phyhealth Provides Update to Shareholders 4Health News:Medco Announces Date for Fourth-Quarter and Full-Year 2008 Financial Results 2Health News:The Truth About 'Bio-identical' Hormone Therapy 2Health News:The Truth About 'Bio-identical' Hormone Therapy 3Health News:The Truth About 'Bio-identical' Hormone Therapy 4
(Date:9/23/2014)... , Sept. 23, 2014 Cerevast Therapeutics ... today the outcome of the first interim analysis ... the Company,s proprietary Clotbust ER TM ... ischemic stroke. The independent Data Safety Monitoring Board ... planned. "Clearing the pre-specified futility threshold ...
(Date:9/23/2014)... therapy recently began in the Czech Republic for ... the United States draws to a close today ... days to live now looks forward to his first day of kindergarten. ... complained of a headache in June, it was the first ... 23, when he completes proton radiation therapy for a brain ...
(Date:9/23/2014)... Sept. 23, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a primary focus on China ... Shrotriya , MD, Chairman and Chief Executive Officer of ... appointment was made in connection with the recently announced ...
Breaking Medicine Technology:Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 2Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 25-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 4CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 3CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 4
... SAN DIEGO, May 7, 2012  Halozyme Therapeutics, Inc. (NASDAQ: ... the quarter ended March 31, 2012. (Logo:  ... milestone in the first quarter with the European regulatory ... Roche," said Gregory I. Frost, Ph.D., President and Chief ...
... May 7, 2012 The National Council on ... customized, online educational modules to promote safe use ... in America, acetaminophen, is found in more than ... relievers, fever reducers, and sleep aids as well ...
Cached Medicine Technology:Halozyme Reports First Quarter 2012 Financial Results 2Halozyme Reports First Quarter 2012 Financial Results 3Halozyme Reports First Quarter 2012 Financial Results 4Halozyme Reports First Quarter 2012 Financial Results 5Halozyme Reports First Quarter 2012 Financial Results 6Safe Use of Acetaminophen 2Safe Use of Acetaminophen 3Safe Use of Acetaminophen 4
... manufactures slides that are compatible with multichannel ... the number of pipetting steps required to ... on the slides. Ask Immuno Concepts for ... slides. These slide formats are noted with ...
... ANA uses a patented HEp-2 cell line ... the sensitivity to SS-A/Ro autoantibodies, without affecting ... studies have been published worldwide on the ... to SS-A/Ro autoantibodies when used in place ...
... and ENA assays can be used ... antinuclear antibodies, which are associated with ... Systemic lupus erythematosus (Lupus), Sjgren's syndrome, ... sclerosis, scleroderma, polymyositis, dermatomyositis, and Raynaud's ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
Medicine Products: